These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 12956741

  • 1. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G, Brönnimann M, Hunziker T, Müller U.
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [Abstract] [Full Text] [Related]

  • 2. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F, Wenderoth A, Przybilla B.
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [Abstract] [Full Text] [Related]

  • 3. Mastocytosis and insect venom allergy.
    Bonadonna P, Zanotti R, Müller U.
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [Abstract] [Full Text] [Related]

  • 4. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI, Eng PA.
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [Abstract] [Full Text] [Related]

  • 6. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly.
    Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G, Burow G, Mitev V, Biedermann T.
    Allergy; 2010 Jul; 65(7):919-23. PubMed ID: 20121769
    [Abstract] [Full Text] [Related]

  • 7. Two cases of elevated tryptase in abdominal aortic aneurysm.
    Pastorello EA, Schroeder JW, Veronese SM, Pravettoni V, De Gasperi A, Cantoni S, Losappio L, Farioli L, Qualizza R, Scarpati B, Mascheri A, Scibilia J.
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):58-61. PubMed ID: 25781196
    [Abstract] [Full Text] [Related]

  • 8. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R, Glück J, Jawor B, Rogala B.
    Immunopharmacol Immunotoxicol; 2015 Mar; 37(4):375-9. PubMed ID: 26181651
    [Abstract] [Full Text] [Related]

  • 9. Hymenoptera venom immunotherapy and field stings.
    Lang R, Hawranek T.
    J Investig Allergol Clin Immunol; 2006 Mar; 16(4):224-31. PubMed ID: 16889279
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A, Lavigne C, Chappard D, Verret JL, Chevailler A, Nicolie B, Drouet M.
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [Abstract] [Full Text] [Related]

  • 11. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M, Helbling A, Schwartz L, Müller U.
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM, Van Hoeyveld EM, Stevens EA.
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [Abstract] [Full Text] [Related]

  • 13. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, Mozafari H, Mohammadzadeh I, Chavoshzadeh Z, Shirkhoda Z.
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [Abstract] [Full Text] [Related]

  • 14. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y, Nashef F, Cohen-Engler A, Meir-Shafrir K, Lachover-Roth I, Confino-Cohen R.
    Int Arch Allergy Immunol; 2019 Dec; 180(2):128-134. PubMed ID: 31216540
    [Abstract] [Full Text] [Related]

  • 15. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR.
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [Abstract] [Full Text] [Related]

  • 16. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S, Graf N, Johansen P, Müllner G, Kündig TM, Senti G.
    Int Arch Allergy Immunol; 2013 Apr; 160(1):86-92. PubMed ID: 22948338
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis of Hymenoptera venom allergy.
    Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, EAACI Interest Group on Insect Venom Hypersensitivity.
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [Abstract] [Full Text] [Related]

  • 18. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R, Lombardo C, Passalacqua G, Caimmi C, Bonifacio M, De Matteis G, Perbellini O, Rossini M, Schena D, Busa M, Marcotulli MC, Bilò MB, Franchini M, Marchi G, Simioni L, Bonadonna P.
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [Abstract] [Full Text] [Related]

  • 19. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Jul; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 20. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
    Ruëff F, Vos B, Oude Elberink J, Bender A, Chatelain R, Dugas-Breit S, Horny HP, Küchenhoff H, Linhardt A, Mastnik S, Sotlar K, Stretz E, Vollrath R, Przybilla B, Flaig M.
    Clin Exp Allergy; 2014 Jul; 44(5):736-46. PubMed ID: 24447114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.